Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors

Neuropharmacology

Volumn 36, Issue 6, 1997, Pages 787-792

  Thorn, L ^a   Ashmeade, T E ^a   Storey, V J ^a   Routledge, C ^a   Reavill, C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Amphetamine; Dopamine; Dopamine D2 receptor; Dopamine D3 receptor; Locomotor activity; Microdialysis; Quinelorane

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; QUINELORANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AMPHETAMINE; ANIMALS; DOPAMINE; DOPAMINE AGONISTS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 0030790282     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00033-6     Document Type: Article

References (34)

1. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and reserpine-treated rat. Eur. J. Pharmacol. 260 (2-3): 177-181.
2. 2 receptor mRNA. Brain Res. 564: 203-219.
3. Daly S. A. and Waddington J. L. (1993) Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology 32: 509-510.
4. 3 receptor ligand. Eur. J. Pharmacol. 249: R9-R10.
5. 3 receptor in the rat brain. Neuroscience 65 (3): 731-745.
6. 3 dopamine autoreceptor in regulation of dopamine release but not synthesis in nucleus accumbens and dorsal striatum of freely moving rats. Behav. Pharmacol. 6 (Supp. 1): 74-75.
7. 3 receptor in the presynaptic regulation of dopamine release but not synthesis. Eur. J. Pharmacol. 308: 261-269.
8. 3 autoreceptor-mediated effects? Pharmacol. Biochem. Behav. 52 (2): 275-280.
9. Gobert A., Rivet J. M., Audinot V., Cistarelli L., Spedding M., Vian J., Peglion J. L. and Millan M. J. (1995) Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J. Pharmacol. Exp. Ther. 275 (2): 899-913.
10. 2 receptor. Clin. Neuropharmacol. 18: S130-S142.
11. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res. 648: 222-228.
12. Hutson P. H., Bristow L. J., Thorn L. and Tricklebank M. D. (1991) R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br. J. Pharmacol. 103: 2037-2044.
13. 3 receptor binding affinities. Eur. J. Pharmacol. 277: 209-214.
14. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Mol. Brain. Res. 18: 187-192.
15. Macdonald E., Haapalinna A., Virtanen R. and Lammintausta R. (1989) Effects of acute administration of medetomidine on the behaviour, temperature and turnover rates of brain biogenic amines in rodents and reversal of these effects by atipamezole. Acta Vet. Scand. 85: 77-81.
16. Millan M. J., Audinot V., Rivet J. M., Gobert A., Vian J., Prost J. F., Spedding M. and Peglion J. L. (1994) S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats. Eur. J. Pharmacol. 260 (2-3): R3-5.
17. Millan M. J., Peglion J. L., Vian J., Rivet J. M., Brocco M., Gobert A., Newman-Tancredi A., Dacquet C., Bervoets K. and Girardon S. (1995) Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy. J. Pharmacol. Exp. Ther. 275 (2): 885-898.
18. Paxinos S. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
19. 3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275: 1355-1366.
20. Radhakishun F. S. and Van Ree J. M. (1987) The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Eur. J. Pharmacol. 137 (1): 41-47.
21. 2 receptors. Neuroreport 6: 320-332.
22. 2 receptors. Psychopharmacology 89: S32.
23. 3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc. Natn. Acad. Sci. U.S.A. 90: 8942-8946.
24. Sessions G. R., Meyerhoff J. L., Kant G. J. and Koob G. F. (1980) Effects of lesions of the ventral medial tegmentum on locomotor activity, biogenic amines and response to amphetamine in rats. Pharmacol. Biochem. Behav. 12: 603-608.
25. Skirboll L. R., Grace A. A. and Bunney B. S. (1979) Dopamine auto- and post-synaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206: 80-82.
26. 2 receptor. Eur. J. Pharmacol. 225: 331-337.
27. 3) as a target for neuroleptics. Nature 347: 146-151.
28. Ståhle L. (1992) Do autoreceptors mediate dopamine agonist-induced yawning and suppression of exploration? A critical review. Psychopharmacology 106: 1-13.
29. Stähle L. and Ungerstedt U. (1989) Yawning and suppression of exploration in amphetamine-treated rats, incompatibility with the autoreceptor hypothesis. Psychopharmacology 97: 553-560.
30. Storey V. J., Middlemiss D. N. and Reavill C. (1995) Effect of haloperidol and (-) sulphide on dopamine agonist-induced hypoactivity. Neuropharmacology 34: 449-55.
31. Svensson L. and Ahlenius S. (1983) Suppression of exploratory locomotor activity by the local application of dopamine or l-noradrenaline to the nucleus accumbens of the rat. Pharmacol. Biochem. Behav. 19 (4): 693-699.
32. 3 ligand #-(+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural. Transm. 95: 71-74.
33. 3 receptors are located post-synaptically. British Dopamine Group Meeting, p. 9.
34. 3 receptor:- a post-synaptic receptor inhibitory on rat locomotor activity. J. Neural. Transm. 94: 11-19.